Anemia in chronic obstructive pulmonary disease: Epidemiology and economic implications

Current Medical Research and Opinion

Volumn 24, Issue 4, 2008, Pages 1123-1130

  Shorr, Andrew F ^a   Doyle, John ^b   Stern, Lee ^b   Dolgitser, Margarita ^b   Zilberberg, Marya D ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Analytica International   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Anemia; Chronic obstructive pulmonary disease; Cost; Economics

Indexed keywords

HEMOGLOBIN;

AGE; AGED; ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PREVALENCE; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPIROMETRY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANEMIA; DATABASES AS TOPIC; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 42549138483     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X280699     Document Type: Article

References (37)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-20
2. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9
3. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. JAMA 1997;277:246-53
4. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997;127:1072-9
5. Osman LM, Godden DJ, Friend JAR, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52:67-71
6. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680-5
7. Halpern MT, Stanford RH, Borker R. The burden of COPD in the USA: results from the Confronting COPD survey. Respir Med 200;97:S81-9
8. National Heart Lung and Blood Institute. Morbidity & Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health, 2004
9. Holguin F, Folch E, Redd SC, et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005-11
10. Nordyke RJ, Kim JJ, Goldberg GA, et al. Impact of anemia on hospitalization time, charges, and mortality in patients with heart failure. Value Health 2004;7:464-71
11. Lyman GH, Berndt ER, Kallich JD, et al. The economic burden of anemia in cancer patients receiving chemotherapy. Value Health 2005;8:149-56
12. Ershler WB, Chen K, Reyes EB, et al. Economic burden of patients with anemia in selected diseases. Value Health 2005;8:629-38
13. National Kidney Foundation. K/DOQI clinical practice guidelines for anemia of chronic kidney disease, 2000. Am J Kidney Dis 2001;37(Suppl 1):S182-238
14. Silberberg JS, Rahal DP, Patton R, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 1989;64:222-4
15. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6
16. McMurray JJV. What are the clinical consequences of anemia in patients with chronic heart failure? J Card Fail 2004;10(Suppl):S10-12
17. Sharma R, Francis DP, Pitt B, et al. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 2004;25:1021-8
18. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004;116:27-43S
19. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis 2002;185(Suppl 2):S110-14
20. Pockros PJ, Shiffman ML, Schiff ER, et al. Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy. Hepatology 2004;40:1450-8
21. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in cancer patients. Cancer 2001;91:2214-21
22. Pennix BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004;52:719-24
23. Cote C, Zilberberg MD, Mody S, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007;29:923-9
24. Halpern MT, Zilberberg MD, Schmier JK, et al. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006;4:17
25. Mapel DW, McMillan GP, Frost FJ. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med 2005;99:1325-33
26. World Health Organization. Nutritional anemias: report of a WHO scientific group. WHO Technical Report Series 405. Geneva, Switzerland: World Health Organization, 1968:1-37
27. Kasper DL, Braunwald E, Fauci AS, et al. Anemia and polycythemia. Harrison's Online Dictionary. 2005. Available at http://www3.accessmedicine.com. db.usip.edu/popup.aspx?aID=58150&print=yes. Accessed February 8, 2005
28. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40: 373-83
29. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20
30. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152(5 pt 2):S77-121
31. Niewoehner DE, Collins D, Erbland ML, for the Department of Veterans Affairs Cooperative Study Group. Relation of FEV1 to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1201-5
32. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am Respir Crit Care Med 2001;163:1256-76
33. Guralnik JM, Ersshler WB, Schrier SL, et al. Anemia in the elderly: a public health crisis in hematology. Hematology 2005;1:528-32
34. Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006;6:23
35. John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest 2005;127:825-9
36. Chambellan A, Chailleux E, Similowski T, and the ANTADIR Observatory Group. Prognostic value of hematocrit in patients with severe chronic obstructive pulmonary disease receiving long term oxygen therapy. Chest 2005;128:1201-8
37. Jansson SA, Lindbeck A, Ericsson A, et al. Cost differences for COPD with and without physician diagnosis. COPD 2005;2:427-34